WisdomTree BioRevolution Fund
Name
As of 03/28/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
1.9%
1 yr return
2.4%
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$2.79 M
Holdings in Top 10
21.3%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.45%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 03/28/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
WDNA - Profile
Distributions
- YTD Total Return 1.9%
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.8%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameWisdomTree BioRevolution Fund
-
Fund Family NameWisdomTree Trust
-
Inception DateJun 03, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerMarlene Walker-Smith
Fund Description
The Fund employs a “passive management” – or indexing – investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole.
WisdomTree, Inc., the Index Provider and parent company of the Fund’s investment adviser, WisdomTree Asset Management, Inc. (“WisdomTree Asset Management” or the “Adviser”), designed the Index to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The Index constituents are determined by an Index committee that looks at companies focusing on: the application of genetic technologies to prevent and treat disease; the applications of human genetic technologies to new classes of consumer products personalized for each individual; the transformation of agriculture, aquaculture, and food production, creating healthier and more sustainable models for feeding the growing global population; biological re-engineering used to produce an increasing percentage of the physical inputs needed for manufacturing; and/or DNA as a storage solution (collectively, “BioRevolution Activities”).
To be eligible for inclusion in the Index, a company must meet the following criteria as of the Index screening date: (i) derive at least 50% of its revenue from BioRevolution Activities; (ii) have a market capitalization of at least $300 million; and (iii) have a median daily dollar volume of at least $1 million for each of the preceding three months.
The Index is a modified equally weighted index that is reconstituted and rebalanced semi-annually. The Index Provider currently uses the Global Industry Classification Standard (GICS®), a widely recognized industry classification methodology developed by MSCI, Inc. and Standard & Poor’s Financial Services LLC, to assign companies to a given sector or industry and identify the sectors represented in the Index. The sectors represented in the Index, as well as the extent of such representation, are expected to vary over time. A sector typically is comprised of multiple industries. For example, the Energy Sector is comprised of, among others, the Energy Equipment and Services Industry and the Oil, Gas and Consumable Fuels Industry. As of September 30, 2023, companies assigned to the Health Care Sector comprised a significant portion (i.e., approximately 15% or more of the total weighting) of the Index; however, the Index’s sector exposure may change from time to time.
To the extent the Index concentrates (i.e., holds more than 25% of its total assets) in the securities of companies assigned to a particular industry or group of industries, the Fund will concentrate its investments in such industry to approximately the same extent as the Index.
As of September 30, 2023, the equity securities of companies domiciled in or otherwise tied (e.g., a company’s principal place of business is maintained in that region or country) to each of the United States and Europe comprised a significant portion (i.e., approximately 15% or more of the total weighting) of the Index, although the Index’s geographic exposure may change from time to time.
WDNA - Performance
Return Ranking - Trailing
Period | WDNA Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 1.9% | -25.6% | 23.4% | 98.88% |
1 Yr | 2.4% | -30.0% | 21.8% | N/A |
3 Yr | N/A* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
Period | WDNA Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -2.9% | -53.9% | 11.7% | N/A |
2022 | -26.6% | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
Total Return Ranking - Trailing
Period | WDNA Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 1.9% | -41.2% | 23.4% | 98.88% |
1 Yr | 2.4% | -30.0% | 28.3% | N/A |
3 Yr | N/A* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | WDNA Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -2.1% | -53.9% | 11.7% | N/A |
2022 | -26.3% | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
WDNA - Holdings
Concentration Analysis
WDNA | Category Low | Category High | WDNA % Rank | |
---|---|---|---|---|
Net Assets | 2.79 M | 732 K | 46.2 B | 94.54% |
Number of Holdings | 94 | 21 | 473 | 25.13% |
Net Assets in Top 10 | 574 K | 2.18 K | 21.6 B | 94.76% |
Weighting of Top 10 | 21.27% | 12.3% | 80.8% | 95.81% |
Top 10 Holdings
- State Street Navigator Securities Lending Government Money Market Portfolio 3.77%
- Twist Bioscience Corp 3.29%
- Bridgebio Pharma Inc 2.35%
- Blueprint Medicines Corp 2.19%
- Iovance Biotherapeutics Inc 1.96%
- Editas Medicine Inc 1.60%
- Amicus Therapeutics Inc 1.57%
- Ginkgo Bioworks Holdings Inc 1.54%
- Fate Therapeutics Inc 1.52%
- Eli Lilly Co 1.49%
Asset Allocation
Weighting | Return Low | Return High | WDNA % Rank | |
---|---|---|---|---|
Stocks | 99.81% | 85.37% | 106.13% | 14.14% |
Cash | 3.77% | -0.10% | 9.01% | 90.05% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 57.07% |
Other | 0.00% | -22.99% | 3.38% | 58.64% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 57.07% |
Bonds | 0.00% | 0.00% | 12.39% | 56.54% |
Stock Sector Breakdown
Weighting | Return Low | Return High | WDNA % Rank | |
---|---|---|---|---|
Utilities | 0.00% | 0.00% | 0.00% | 54.97% |
Technology | 0.00% | 0.00% | 22.69% | 58.64% |
Real Estate | 0.00% | 0.00% | 7.13% | 58.12% |
Industrials | 0.00% | 0.00% | 7.02% | 58.12% |
Healthcare | 0.00% | 59.26% | 100.00% | 98.43% |
Financial Services | 0.00% | 0.00% | 1.85% | 68.59% |
Energy | 0.00% | 0.00% | 0.00% | 54.97% |
Communication Services | 0.00% | 0.00% | 9.11% | 57.59% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 1.57% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 57.07% |
Basic Materials | 0.00% | 0.00% | 14.83% | 0.52% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | WDNA % Rank | |
---|---|---|---|---|
US | 87.97% | 53.67% | 104.41% | 74.87% |
Non US | 11.83% | 0.00% | 45.40% | 20.94% |
WDNA - Expenses
Operational Fees
WDNA Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.45% | 0.08% | 3.13% | 81.96% |
Management Fee | 0.45% | 0.00% | 1.25% | 14.75% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
WDNA Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
WDNA Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
WDNA Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | 1.37% |
WDNA - Distributions
Dividend Yield Analysis
WDNA | Category Low | Category High | WDNA % Rank | |
---|---|---|---|---|
Dividend Yield | 0.79% | 0.00% | 2.44% | 62.24% |
Dividend Distribution Analysis
WDNA | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annually | Quarterly | Annually |
Net Income Ratio Analysis
WDNA | Category Low | Category High | WDNA % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | 39.05% |
Capital Gain Distribution Analysis
WDNA | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 28, 2023 | $0.135 | OrdinaryDividend |
Dec 29, 2022 | $0.065 | OrdinaryDividend |
Dec 30, 2021 | $0.025 | OrdinaryDividend |
WDNA - Fund Manager Analysis
Managers
Marlene Walker-Smith
Start Date
Tenure
Tenure Rank
Jun 01, 2021
1.0
1.0%
Marlene is head of equity index portfolio management. She leads the team of equity index portfolio managers managing US and non-US equity index portfolios and is responsible for the refinement and implementation of the entire equity index portfolio management process. Previously, Marlene served as a senior portfolio manager within the equity index team and prior to joining the equity index team was an equity trader for the firm. Prior to joining the firm in 1995, Marlene was a trader for Banc One Investment Advisors Corporation and a brokerage services manager for Mid Atlantic Capital Corporation. Marlene has been in the investment industry since 1990. Marlene earned an MBA in finance from the University of Pittsburgh and a BA in history and Russian from Washington & Jefferson College.
Todd Frysinger
Start Date
Tenure
Tenure Rank
Jun 30, 2021
0.92
0.9%
Mr. Frysinger is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2007.
Vlasta Sheremeta
Start Date
Tenure
Tenure Rank
Jun 30, 2021
0.92
0.9%
Ms. Sheremeta is a vice president and senior portfolio manager at Mellon. She has been employed by Mellon or a predecessor company since 2011.
David France
Start Date
Tenure
Tenure Rank
Jun 30, 2021
0.92
0.9%
Mr. France is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2009.
Michael Stoll
Start Date
Tenure
Tenure Rank
Jun 30, 2021
0.92
0.9%
Mr. Stoll is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2005.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.26 | 2.12 |